Citation

Wright A, Cather C, Gilman J, Evins AE. Child Adolesc. Psychiatr. Clin. N. Am. 2020; 29(1): 145-156.

Affiliation

Harvard Medical School, Boston, MA USA; Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Boston, MA 02114, USA.

Copyright

(Copyright © 2020, Elsevier Publishing)

DOI

10.1016/j.chc.2019.08.016

PMID

31708043

Abstract

The rapidly changing landscape of cannabis in terms of availability, potency, and routes of administration, as well as the decrease in risk perception and changing norms, have contributed to an increase in the popularity of cannabis. Cannabis use is associated with a poorer recovery from a psychotic disorder, increasing the risk of relapse, rehospitalization, and lower social functioning. Data are mixed regarding cannabis use as a component cause of psychosis in people at risk for psychotic disorder. Care providers, parents, and schools must educate youth and adolescents about the risks of cannabis use.

Copyright © 2019 Elsevier Inc. All rights reserved.

Language: en

Keywords

CBD; Cannabis use; First-episode psychosis; High potency; Schizophrenia; THC; Tetrahydrocannabinol